Preleukemia clinical trials

The registry lists 14 studies for Preleukemia across more than 10 countries. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-08-17.

Get an email when these change. Save the Preleukemia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 6
Recruiting: 3
Active, not recruiting: 2
Terminated: 2
No longer available: 1

Phase

Phase 1: 8
Phase 2: 7

Where

United States: 12
France: 3
Germany: 2
Netherlands: 2
United Kingdom: 2
Belgium: 1

Who runs them

Center for International Blood and Marrow Transplant Research (2) · University of Chicago (2) · University Hospital, Tours (1) · Christopher Dvorak (1) · Gustavo Rivero (1) · BlossomHill Therapeutics (1) · Novartis Pharmaceuticals (1) · Kirsten Grønbæk (1)

What is being tested here

Drugs under test in Preleukemia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	All
Partially Engineered T-regulatory Cell Donor Graft TRGFT-201	1	1
Metformin	1	1
Melphalan	0	4
Busulfan	0	2
Cyclophosphamide	0	2
Fludarabine	0	2
CPI-0610	0	1
Decitabine	0	1
Spartalizumab	0	1
Sabatolimab	0	1

Drug classes tested here Alkylating agents 4 · Antimetabolites 4

Coming up

0phase 3 studies under way

2studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 2

Dec 2026HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis · Center for International Blood and Marrow Transplant Research
Nov 2027Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome · Orca Biosystems, Inc.

Who these studies take

Of the 3 Preleukemia studies recruiting now, 3 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (33%) take healthy volunteers.

Recruiting studies that take each age, of 3
Age	Women	Men
10	0 (0%)	0 (0%)
18	3 (100%)	3 (100%)
30	3 (100%)	3 (100%)
40	3 (100%)	3 (100%)
50	3 (100%)	3 (100%)
65	3 (100%)	3 (100%)
75	3 (100%)	3 (100%)
85	3 (100%)	3 (100%)

Across all 14 studies, recruiting or not: 14% stop at 75 or younger and 7% at 65; 21% take children; 0% are for women only and 0% for men only; 14% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 14 of 14. search them.